BioControl Medical, Ltd. was founded in 1999 by Yossi Gross, and is based in Yehud, Israel. BioControl’s first devices were developed to treat incontinence due to overactive bladder, stress, and interstitial cystitis. In 2006 American Medical Sytems acquired an exclusive license for the use of the technology in urology, gynecology and other pelvic health applications.
Since then, BioControl has been focusing on vagus nerve stimulation. Its product – CardioFit – is an implantable electrical stimulation device designed to restore balance in the autonomic nervous system and improve heart function in patients with heart failure. This device is intended to directly activate the parasympathetic branch of the autonomic nervous system for the treatment of heart failure, and operates by stimulating the vagus nerve on the right side of the neck. In December 2008, BioControl Medical received the CE Mark for CardioFit system.
Recently, BioControl spun-off CerebralRx to launch its FitNeS vagus nerve stimulation system for the treatment of refractory epilepsy.
Company website: www.biocontrol-medical.com
Click here for BioControl’s patents